background
human
rhinoviru
hrv
respons
major
common
cold
frequent
accompani
secondari
bacteri
infect
poorli
understood
mechan
investig
effect
experiment
human
hrv
serotyp
infect
upper
respiratori
tract
microbiota
method
six
healthi
volunt
infect
perform
ribosom
rnatarget
pyrosequenc
throat
swab
taken
prior
infect
compar
overal
commun
divers
phylogenet
structur
ecosystem
rel
abund
differ
bacteria
time
point
result
acut
infect
strong
trend
toward
increas
rel
abund
haemophilu
parainfluenza
neisseria
subflava
observ
well
weaker
trend
toward
increas
staphylococcu
aureu
major
differ
observ
day
wherea
differ
subject
high
conclus
infect
associ
increas
three
genera
known
associ
secondari
infect
follow
hrv
infect
observ
chang
upper
respiratori
tract
microbiota
could
help
explain
hrv
infect
predispos
bacteri
otiti
media
sinus
pneumonia
human
rhinoviru
global
endem
viru
belong
famili
picornavirida
common
caus
common
cold
although
usual
caus
mild
moder
diseas
hrv
trigger
exacerb
chronic
obstruct
pulmonari
diseas
asthma
cystic
fibrosi
may
caus
sever
lower
respiratori
tract
diseas
particularli
risk
group
infant
elderli
immunocompromis
patient
addit
infect
hrv
predispos
factor
secondari
bacteri
infect
otiti
media
sinus
pneumonia
insight
mechan
hrv
enhanc
bacteri
suprainfect
remain
limit
hrv
associ
bacteri
superinfect
assum
caus
part
anatom
mechan
caus
eg
due
eustachian
tube
dysfunct
ostiomeat
obstruct
reduc
mucocilliari
clearanc
addit
hrv
infect
may
increas
epitheli
permeabl
promot
bacteri
adher
entri
epithelium
reduc
host
respons
bacteri
pathogen
common
pathogen
associ
hrvassoci
bacteri
infect
includ
pneumonia
h
influenza
catarrhali
recent
year
cultureindepend
dnabas
techniqu
demonstr
highli
complex
microbi
commun
present
upper
airway
commun
integr
part
commens
airway
microbiota
like
contribut
infect
diseas
hrv
infect
subsequ
host
respons
chang
upper
airway
local
environ
like
alter
microbiota
composit
insight
hrv
induc
chang
microbiota
composit
could
contribut
understand
pathophysiolog
mechan
bacteri
superinfect
could
help
predict
secondari
bacteri
infect
therebi
ultim
contribut
prevent
strategi
tool
human
studi
date
retrospect
show
epidemiolog
correl
hrv
presenc
potenti
respiratori
pathogen
correl
howev
necessarili
implic
causal
interpret
data
warrant
caution
studi
lung
microbiota
crosssect
observ
descript
natur
describ
effect
hrv
infect
upper
respiratori
tract
microbiota
otherwis
healthi
human
volunt
experiment
infect
hrv
serotyp
enabl
control
observ
resolut
infect
hypothes
infect
alter
throat
bacteri
microbiota
composit
healthi
volunt
term
bacteri
divers
shannon
simpson
divers
index
well
bacteri
rich
measur
also
analys
chang
time
rel
abund
individu
bacteri
generaspeci
healthi
volunt
total
age
elig
particip
provid
common
cold
six
week
prior
enrol
presenc
common
cold
defin
cumul
valid
cold
symptom
score
day
period
subject
impress
cold
rhinorrhoea
least
three
day
exclus
criteria
receipt
bcgvaccin
chest
xray
abnorm
histori
lung
diseas
sign
airway
obstruct
forc
expiratori
volum
predict
valu
season
perenni
rhiniti
sinus
smoke
unless
stop
smoke
month
prior
studi
max
pack
year
clinic
signific
abnorm
medic
histori
clinic
examin
particip
clinic
investig
drug
treatment
protocol
within
day
enrol
pregnanc
lactat
medic
usag
studi
protocol
approv
academ
medic
center
amsterdam
ethic
review
committe
written
inform
consent
obtain
volunt
prospect
singl
center
studi
volunt
experiment
infect
fig
upon
enrol
volunt
screen
ensur
absenc
circul
antibodi
tuberculosi
human
tlymphotrop
viru
type
human
immunodefici
viru
hiv
hepat
b
c
viru
hav
hbv
hcv
acut
infect
influenza
b
enteroviru
sp
adenoviru
sp
rhinoviru
sp
human
metapneumoviru
human
respiratori
syncyti
viru
sp
parainfluenza
virus
human
parechoviru
human
bocaviru
coronaviru
sp
chlamydia
pneumonia
mycoplasma
pneumonia
legionella
sp
exclud
valid
pcr
assay
nasal
lavag
throat
swab
throat
swab
collect
serv
baselin
microbiota
measur
one
day
later
volunt
experiment
infect
detail
shown
caus
mild
commoncold
symptom
nasal
lavag
throat
swab
perform
daili
day
day
convalesc
throat
swab
taken
volunt
request
report
common
cold
asthma
symptom
daili
day
rhinoviru
challeng
use
standard
cold
symptom
score
diari
collect
final
visit
experiment
infect
induc
describ
previous
short
aliquot
store
kept
ice
thaw
dilut
steril
nacl
exposur
dilut
transfer
steril
micron
tube
posit
glass
support
devilbiss
atom
devilbiss
healthcar
somerset
pa
usa
dilut
administ
healthi
volunt
spray
one
nostril
close
nostril
total
administ
dose
infect
confirm
posit
pcr
posit
viral
cultur
develop
symptom
one
nostril
close
use
inflat
cathet
describ
previous
slowli
ml
steril
hank
balanc
salt
solut
without
phenol
bodi
temperatur
instil
via
cathet
left
min
lavag
fluid
collect
tube
viral
detect
procedur
repeat
nostril
use
materi
steril
disinfect
use
ethanol
prior
use
cottontip
swab
copan
diagnost
corona
canada
use
obtain
materi
space
palatin
arch
cotton
swab
transfer
univers
transport
medium
utm
copan
diagnost
tightli
close
tube
vortex
swab
discard
medium
store
infect
confirm
hrvposit
quantit
pcr
nasal
andor
throat
sampl
describ
elsewher
addit
presenc
replicationcompet
hrv
confirm
viru
cultur
human
embryon
lung
cell
treatment
inhous
enzymat
cocktail
achromopeptidas
mutanolysin
lysostaphin
lysosym
mgml
sigmaaldrich
st
loui
mo
usa
tebuff
well
inhous
lysi
buffer
sodiumdocecylsulph
sarkosyl
tebuff
dna
extract
use
magnapur
lc
roch
diagnost
indianapoli
usa
follow
manufactur
instruct
bacteri
rrna
gene
quantifi
rtpcr
use
primer
bind
area
rrna
gene
conserv
bacteria
probe
subsequ
rrna
gene
amplifi
use
primer
detail
supplementari
materi
follow
second
round
pcr
use
primer
adapt
barcod
see
addit
file
full
descript
amplifi
fragment
adapt
tag
quantifi
use
quantit
dsdna
assay
kit
qubit
fluoromet
data
analysi
perform
use
softwar
quantit
insight
microbi
ecolog
qiim
remov
low
qualiti
read
qualiti
score
chimera
chimeraslay
data
denois
use
qiim
denois
program
cluster
sequenc
oper
taxonom
unit
otu
base
sequenc
similar
uclust
result
otu
tabl
condens
remov
otu
repres
less
total
number
sequenc
uclust
classifi
use
assign
taxonomi
fasttre
use
construct
phylogenet
tree
downstream
analys
bacteri
taxonom
rich
divers
determin
use
rarefact
plot
normal
number
sequenc
per
time
point
rarefact
curv
gener
genet
differ
level
eg
genu
level
shannon
divers
measur
quantit
measur
reflect
number
differ
speci
simultan
take
account
evenli
bacteria
distribut
among
speci
anoth
method
examin
microbiota
commun
structur
use
measur
estim
minimum
rich
sampl
take
account
number
speci
found
singleton
twice
doubleton
sampl
provid
estim
number
undetect
speci
microbiota
import
human
associ
microbiota
contain
mani
rare
speci
unifrac
method
calcul
distanc
measur
sampl
use
phylogenet
tree
unifrac
measur
express
fraction
share
branch
phylogenet
tree
sampl
ecolog
intraand
interpati
microbiota
similar
estim
use
adoni
anosim
mrpp
method
includ
qiim
briefli
method
compar
ecolog
distanc
sampl
unifrac
distanc
test
null
hypothesi
intragroup
similar
significantli
differ
intergroup
similar
sampl
size
n
expect
abl
detect
effect
bacteri
rich
measur
twosid
signific
p
power
assum
standard
deviat
normal
data
calcul
otu
proportionth
fig
studi
design
screen
perform
day
experiment
rhinoviru
infect
nasal
wash
throat
swab
human
rhinoviru
hrv
pcr
viral
cultur
repeat
daili
day
day
throat
swab
rrna
gene
sequenc
collect
prior
challeng
day
subsequ
day
day
proport
total
sequenc
per
microbi
commun
ie
per
sampl
compar
differ
microbiota
member
time
point
use
linear
mix
model
microbi
commun
comparison
perform
use
parametr
statist
r
p
valu
correct
multipl
hypothesi
test
use
fals
discoveri
rate
fdr
assess
differ
overal
commun
structur
data
volunt
pool
per
time
point
divers
measur
alpha
divers
measur
shannon
index
simpson
index
consid
alpha
divers
indic
ie
shannon
divers
sensit
origin
number
sequenc
gener
given
sampl
calcul
shannon
simpson
divers
normal
number
sequenc
separ
sampl
number
randomli
pick
read
correspond
lowest
number
sequenc
sampl
group
pick
time
sequenc
set
total
volunt
male
femal
includ
studi
age
rang
year
infect
establish
demonstr
posit
hrv
pcr
posit
viral
cultur
data
shown
develop
symptom
viral
rna
load
nasal
wash
throat
swab
cold
symptom
score
shown
fig
remov
sequenc
repres
less
total
abund
median
number
sequenc
per
sampl
min
max
sd
sequenc
cluster
sequenc
ident
oper
taxonom
unit
otu
identifi
taxonom
analysi
identifi
bacteri
phyla
contain
genera
success
identifi
confid
commonli
amplifi
bacteri
phyla
proteobacteria
bacteroidet
actinobacteria
firmicut
vari
significantli
time
fig
streptococcu
prevotella
veillonella
rothia
haemophilu
common
bacteri
genera
amplifi
togeth
account
total
number
sequenc
genera
contain
speci
level
otu
success
identifi
sequenc
similar
alpha
divers
measur
shannon
simpson
index
similar
specimen
obtain
baselin
convalesc
day
infect
day
principl
coordin
analysi
base
weight
unifrac
measur
fraction
share
branch
phylogenet
tree
reveal
sampl
seem
cluster
individu
volunt
although
substanti
overlap
individu
fig
measur
ecolog
cluster
adoni
anosim
mrpp
show
intraindividu
unifrac
distanc
sampl
lower
interindividu
sampl
distanc
analysi
data
pool
time
point
base
unifrac
measur
reveal
signific
differ
time
point
weight
unifrac
signific
p
data
shown
time
point
infect
significantli
differ
time
point
preinfect
convalesc
use
unifrac
distanc
measur
assess
chang
microbiota
composit
individu
baselin
also
reveal
signific
differ
time
point
fig
among
abundantli
identifi
genera
three
streptococcu
prevotella
rothia
show
limit
variat
infect
less
baselin
abund
wherea
veillonella
decreas
approxim
haemophilu
increas
pair
comparison
use
linear
mix
model
use
assess
chang
time
within
individu
day
group
baselin
noninfect
measur
fig
human
rhinoviru
infect
represent
total
cold
symptom
score
assess
daili
questionnair
well
viral
load
measur
rtpcr
nasal
lavag
fluid
throat
swab
healthi
volunt
nasal
inocul
human
rhinoviru
serotyp
day
group
infect
measur
signific
chang
observ
day
day
specimen
genu
speci
level
howev
genu
level
signific
increas
p
rel
abund
haemophilu
neisseria
observ
infect
analysi
genera
speci
level
show
significantli
increas
haemophilu
parainfluenza
pvalu
neisseria
subflava
pvalu
howev
fals
discoveri
rate
fdr
correct
multipl
comparison
show
threshold
risk
typei
error
taxa
fdr
addit
largest
foldchang
observ
increas
abund
genu
staphylococcu
p
fdr
repres
total
sequenc
identifi
fig
analysi
speci
level
show
weak
trend
toward
increas
staphylococcu
aureu
abund
pvalu
fdr
increas
h
parainfluenza
infect
observ
volunt
neisseria
speci
increas
volunt
staphylococcu
aureu
present
four
volunt
increas
three
henc
observ
correl
staphylococcu
aureu
weakest
pvalu
fdr
observ
chang
microbiota
composit
correl
viral
load
symptom
score
data
shown
studi
demonstr
first
time
infect
otherwis
healthi
volunt
alter
upper
respiratori
tract
microbiota
composit
although
overal
chang
moder
increas
rel
abund
bacteri
genera
haemophilu
staphylococcu
neisseria
observ
speci
level
increas
observ
haemophilu
parainfluenza
staphylococcu
aureu
neisseria
subflava
speci
increas
genera
speci
infect
observ
nearli
volunt
carri
baselin
rel
abund
return
baselin
level
infect
clear
due
limit
number
studi
subject
n
stringent
correct
multipl
observ
chang
reach
statist
signific
nevertheless
strike
one
hundr
genera
detect
substanti
increas
record
genera
gener
associ
secondari
bacteri
infect
infect
heamophilu
staphylococcu
find
suggest
chang
composit
resid
microbiota
per
se
may
play
role
particular
increas
haemophilu
sp
neisseria
sp
observ
howev
contrast
find
microbiota
hrv
infect
healthi
volunt
ie
without
copd
studi
molyneaux
et
al
seem
affect
may
explain
differ
studi
design
eg
use
sputum
specimen
vs
throat
swab
interestingli
asymptomat
aborigin
children
presenc
hrv
significantli
associ
presenc
h
influenza
catarrhali
nasopharyng
aspir
dutch
cohort
otitispron
children
hrv
posit
significantli
associ
presenc
streptococcu
pneumonia
catarrhali
nasopharynx
h
influenza
later
studi
healthi
children
show
h
influenza
posit
associ
presenc
hrv
vitro
studi
demonstr
infect
hrv
induc
chang
microbiota
habitat
augment
adhes
bacteri
pathogen
airway
epithelium
given
complex
upper
airway
ecosystem
seem
like
direct
virobacteri
well
bacterialbacteri
interact
may
also
play
role
although
number
direct
interact
identifi
role
hrv
infect
remain
elucid
present
new
data
cultureindepend
classif
bacteria
present
throat
upper
respiratori
tract
infect
contribut
understand
upper
respiratori
tract
microbi
commun
infect
possibl
polymicrobi
interact
despit
statist
limit
mention
observ
trend
occur
nearli
individu
involv
usual
suspect
secondari
bacteri
infect
avail
volunt
studi
rel
young
extrapol
find
age
group
done
caution
strength
studi
stringent
exclus
presenc
respiratori
pathogen
cultur
independ
next
gener
sequenc
approach
allow
suffici
depth
identifi
even
rarer
speci
sampl
howev
deeper
sequenc
might
reveal
minor
differ
commun
composit
furthermor
studi
fig
principl
compon
analysi
unifrac
measur
sampl
colour
individu
volunt
red
triangl
volunt
blue
triangl
volunt
brown
triangl
volunt
green
circl
volunt
purpl
squar
volunt
yellow
triangl
gener
sampl
seem
cluster
individu
although
substanti
overlap
individu
signific
chang
time
weight
unifrac
signific
signific
differ
infect
vs
noninfect
sampl
weight
unifrac
signific
underpow
investig
differ
individu
bacteri
speci
upper
respiratori
tract
microbiota
limit
inher
sequenc
gene
gener
includ
possibl
bia
introduc
extract
amplif
sequenc
methodolog
final
number
genom
copi
vari
consider
bacteria
bacteria
current
insuffici
knowledg
exact
copi
number
correct
although
abl
observ
chang
within
volunt
infect
includ
group
uninfect
volunt
howev
sinc
volunt
function
control
human
microbiota
health
shown
rel
stabl
time
like
observ
microbiota
chang
induc
infect
although
exclud
possibl
daili
collect
throat
swab
may
affect
microbiota
composit
approach
reduc
background
nois
inher
human
microbiota
studi
mainli
due
larg
differ
individu
way
expect
precis
detect
relev
chang
microbiota
fact
use
sequenti
sampl
allow
us
use
linear
mix
model
nonindepend
pair
sampl
focuss
respons
variabl
interest
bacteri
taxa
cours
experi
minim
background
nois
high
variabl
individu
find
clinic
relev
may
contribut
understand
earli
stage
develop
bacteri
complic
acut
otiti
media
sinus
pneumonia
follow
hrv
respiratori
viral
infect
larger
control
serial
sampl
studi
experiment
natur
occur
hrv
infect
warrant
confirm
extend
current
observ
would
clinic
interest
investig
whether
clinic
secondari
bacteri
infect
hrv
infect
actual
preced
similar
chang
microbiota
composit
conclus
studi
show
infect
associ
strong
trend
toward
increas
rel
abund
haemophilu
neisseria
weaker
trend
toward
increas
rel
abund
staphylococcu
even
observ
chang
upper
respiratori
tract
microbiota
minor
overal
may
great
clinic
signific
could
help
explain
hrv
infect
predispos
bacteri
otiti
media
sinus
pneumonia
